Clinical trial

A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1

NCT00852007

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-02-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2009-02-01Date precision: month

Registry last updated2016-09-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

DC-Tn-MUC1: autologous dendritic cells expressing Tn-MUC1BIOLOGICAL

Sponsors & collaborators

Hamilton Health Sciences Corporationlead sponsor

McMaster Universitycollaborator

Mapped research locations

HamiltonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00852007 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.